Marcio A Fagundes, MD

Michael S. Porrazzo, M.D., is a board-certified radiation oncologist at Baptist Health Miami Cancer Institute. He has more than 30 years of experience utilizing radiation therapy to treat a wide range of cancers, including prostate, breast, head and neck, skin and lung. He has clinical expertise in stereotactic radiosurgery, intensity modulated radiotherapy, transperineal prostate implantation, mammosite breast radiotherapy, cardiovascular radiotherapy and interstitial brachytherapy. Prior to joining Baptist Health, Dr. Porrazzo served as the medical director of radiation oncology and clinical assistant professor of radiation oncology at Beaufort Memorial New River Cancer Center in Okatie, S.C. Dr. Porrazzo earned his medical degree at Meharry Medical College in Nashville. He completed an internal medicine internship at the University of Miami Miller School of Medicine and a radiation oncology residency at SUNY- Health Science Center, State University Hospital in Brooklyn. As a clinician-educator, Dr. Porrazzo is committed to educating the next generation of healthcare professionals. He also contributes to the medical community as a member of the American Society for Therapeutic Radiology and Oncology. To help his patients make the best choices for their unique health situation, Dr. Porrazzo strives to put them at ease, prioritizes their goals and expectations and provides them with education and support. He serves as his patients’ trusted companion during their cancer journey. During his free time, Dr. Porrazzo enjoys spending time with his three adult children, collecting miniature cars and rescuing dogs.

Jean-Marie Stephan, M.D., is a board-certified gynecologic surgical oncologist at Baptist Health South Florida. Dr. Stephan specializes in gynecological cancer prevention, gynecological cancer surgery and chemotherapy. He is fluent in English, French, Arabic and conversational Spanish.Prior to joining Baptist Health South Florida in 2022, Dr. Stephan served as a gynecological oncologist and assistant clinical professor at Rush University Medical Center in Chicago. At the center, he was also the lead investigator of clinical trials to help patients have access to novel therapies.Dr. Stephan’s research has been published in Clinical Obstetrics and Gynecology, Gynecologic Oncology and the American Journal of Obstetrics and Gynecology.He is a member of the Society of Gynecologic Oncology, American Society of Clinical Oncology, American Congress of Obstetricians and Gynecologists, and the American Medical Association.Dr. Stephan takes a holistic approach to healthcare, believing patients and their families should play major roles in decision-making. He develops a tailored treatment plan to meet the unique needs and expectations of each patient.When he is not treating patients, he enjoys spending time with his friends and family, listening to music and playing soccer.

Murugesan Manoharan, M.D., FRACS, is a surgical urologic oncologist and the chief of urologic oncology surgery at Miami Cancer Institute. Dr. Manoharan specializes in the treatment of genitourinary cancers, including bladder, kidney, prostate and testicular cancer. Dr. Manoharan also serves as the chairman of the Department of Urology at Baptist Health South Florida and a professor of urology at Herbert Wertheim College of Medicine, Florida International University.In 2022, the Abbhi Family Endowed Chair in Urologic Oncology was created to help Dr. Manoharan and the Institute conduct research and clinical trials to improve survival rates and quality of life for patients with bladder cancer.He joined Miami Cancer Institute from the Sylvester Comprehensive Cancer Center, where he served as one of the site disease group leaders for genitourinary cancers. He also practiced urology at Jackson Memorial Hospital and the Veterans Affairs Medical Center in Miami.Dr. Manoharan is a renowned leader in the treatment of prostate cancer, kidney cancer, bladder cancer and other urologic malignancies. He is an expert in minimally invasive surgery, including nerve sparing robotic prostatectomy, robotic kidney surgery, robotic bladder removal and neobladder reconstruction. Dr. Manoharan was one of the first urologists in the United States to perform robotic bladder removal surgery and reconstruction of neobladder using a Pfannenstiel incision. He also specializes in other minimally invasive ablative cancer procedures, such as high-intensity focused ultrasound (HIFU) therapy, cryotherapy and the NanoKnife procedure to treat prostate cancer. He has extensive experience training medical students, residents and oncology fellows. He has won numerous awards for his teaching and clinical excellence, as well as his research work. Dr. Manoharan’s research interests include stem cell applications, biomarkers and cancer outcomes. He serves as an editorial reviewer for several scientific publications. He is also widely published in peer-reviewed medical journals and is an invited speaker at national and international scientific symposiums. Dr. Manoharan has authored more than 140 scientific articles and 15 textbook chapters and has presented papers and posters at more than 100 national and international meetings. He served as vice chairman and a member of the International Bladder Cancer Guidelines committee, organized by the WHO and Société Internationale d'Urologie.When he is not treating patients, Dr. Manoharan enjoys music and traveling.